Challenges for the new Cancer Drugs Fund-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Challenges for the new Cancer Drugs Fund

Published:2016-04 Issue:4 Volume:17 Page:416-418
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Littlejohns Peter,Weale Albert,Kieslich Katharina,Wilson James,Rumbold Benedict,Max Catherine,Rid Annette

Funder

King's College Hospital NHS Foundation Trust

Collaboration for Leadership in Applied Health Research and Care - Greater Manchester

Publisher

Elsevier BV

Subject

Oncology

Reference7 articles.

1. The cancer technology appraisal programme of the UK's National Institute for Clinical Excellence;Littlejohns;Lancet Oncol,2003

2. Evidence-based decision making: when should we wait for more information?;Chalkidou;Health Aff,2008

3. The importance of being NICE;Rid;J R Soc Med,2015

4. Continuing the multiple sclerosis risk sharing scheme is unjustified;McCabe;BMJ,2010

5. Coverage options for promising technologies: Medicare's ‘coverage with evidence development’;Tunis;Health Aff,2006

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scoping Review of International Experience of a Dedicated Fund to Support Patient Access to Cancer Drugs: Policy Implications for Thailand;International Journal of Health Policy and Management;2024-01-28

2. Real-World Assessment of Cancer Drugs Using Local Data Uploaded to the Systemic Anti-Cancer Therapy Dataset in England;Clinical Oncology;2022-08

3. Public values and plurality in health priority setting: What to do when people disagree and why we should care about reasons as well as choices;Social Science & Medicine;2021-05

4. The New and Non-Transparent Cancer Drugs Fund;PharmacoEconomics;2019-12-12

5. National Institute for Health and Care Excellence, social values and healthcare priority setting;Journal of the Royal Society of Medicine;2019-04-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3